Cannabis for Pain and Headaches: What Physicians Need to Know
Cannabis compounds including phytocannabinoids, terpenes, and flavonoids show analgesic and anti-inflammatory potential, with dronabinol and nabilone already FDA-approved for other conditions.
Quick Facts
What This Study Found
This primer reviewed the landscape of cannabis-based pain treatment for physicians, covering three main categories of active compounds.
Synthetic cannabinoids like dronabinol and nabilone have already received FDA approval for chemotherapy-related nausea and HIV wasting, providing a regulatory pathway for cannabinoid medicines. Nabiximols (Sativex), a cannabis extract, is approved in Canada and the UK for spasticity and intractable pain.
Beyond THC and CBD, phytocannabinoids have been identified as key compounds with analgesic and anti-inflammatory properties. The review also highlighted other cannabis compounds, including flavonoids and terpenes, that are being investigated for their individual effects and potential synergistic interactions (the "entourage effect").
The authors emphasized the endocannabinoid system as the biological foundation for these effects, noting that the identification of this intrinsic system has opened doors for further research into cannabis-based pain therapies.
Key Numbers
Dronabinol and nabilone are FDA-approved. Nabiximols is approved in Canada and the UK. Clinical trials for seizure disorders were ongoing at publication.
How They Did This
Narrative review of medical literature on cannabis and cannabinoid pharmaceuticals, with emphasis on pain and headache conditions. Covers synthetic cannabinoids, phytocannabinoids, and other cannabis-derived compounds.
Why This Research Matters
This review serves as a practical primer for physicians who are increasingly asked about cannabis for pain. By organizing the evidence around specific compounds and approved medications, it provides a framework for evidence-based clinical conversations.
The Bigger Picture
The review reflects a shift from viewing cannabis as a single substance to understanding it as a complex plant with multiple potentially therapeutic compounds. This more nuanced pharmacological perspective moves the conversation beyond "does cannabis help pain" toward "which cannabis compounds, at what doses, for which types of pain."
What This Study Doesn't Tell Us
Narrative review without systematic methodology or quality assessment. Does not present original data. The headache-specific evidence is particularly sparse. Published before major developments in CBD regulation.
Questions This Raises
- ?Could specific terpene-cannabinoid combinations be optimized for different pain types?
- ?Does the entourage effect hold up under rigorous clinical testing?
- ?Are there headache-specific cannabinoid formulations worth developing?
Trust & Context
- Key Stat:
- Dronabinol and nabilone are already FDA-approved; nabiximols is approved in Canada and the UK
- Evidence Grade:
- Narrative review aimed at clinical education. Moderate because it synthesizes existing evidence but does not conduct systematic analysis.
- Study Age:
- Published in 2017.
- Original Title:
- Cannabis for Pain and Headaches: Primer.
- Published In:
- Current pain and headache reports, 21(4), 19 (2017)
- Authors:
- Kim, Philip S, Fishman, Michael A
- Database ID:
- RTHC-01419
Evidence Hierarchy
Summarizes existing research without a strict systematic method.
What do these levels mean? →Frequently Asked Questions
Are there FDA-approved cannabis medications for pain?
As of this review, dronabinol and nabilone are FDA-approved for nausea and HIV wasting, not directly for pain. Nabiximols (a cannabis extract) is approved for pain and spasticity in Canada and the UK but not the US.
Can cannabis help with headaches?
The review covers cannabis for pain including headaches, but notes that the headache-specific evidence is limited. The analgesic and anti-inflammatory properties of cannabinoids suggest potential, but clinical trials for headaches are needed.
Read More on RethinkTHC
- CBD-oil-quality-guide
- anxiety-medication-after-quitting-weed
- cannabis-chemotherapy-nausea
- cannabis-chronic-pain-research
- cannabis-epilepsy-CBD-Epidiolex
- cbd-anxiety-research-evidence
- cbd-for-weed-withdrawal
- cbd-vs-thc-difference
- medical-benefits-of-cannabis
- quitting-weed-before-surgery
- quitting-weed-medication-interactions
- quitting-weed-pregnancy
- quitting-weed-pregnant
- seniors-older-adults-cannabis-risks-medications
- weed-breastfeeding-THC-breast-milk
Cite This Study
https://rethinkthc.com/research/RTHC-01419APA
Kim, Philip S; Fishman, Michael A. (2017). Cannabis for Pain and Headaches: Primer.. Current pain and headache reports, 21(4), 19. https://doi.org/10.1007/s11916-017-0619-7
MLA
Kim, Philip S, et al. "Cannabis for Pain and Headaches: Primer.." Current pain and headache reports, 2017. https://doi.org/10.1007/s11916-017-0619-7
RethinkTHC
RethinkTHC Research Database. "Cannabis for Pain and Headaches: Primer." RTHC-01419. Retrieved from https://rethinkthc.com/research/kim-2017-cannabis-for-pain-and
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.